Adriano Duatti

3.5k total citations
132 papers, 2.5k citations indexed

About

Adriano Duatti is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Adriano Duatti has authored 132 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Radiology, Nuclear Medicine and Imaging, 44 papers in Pulmonary and Respiratory Medicine and 38 papers in Organic Chemistry. Recurrent topics in Adriano Duatti's work include Radiopharmaceutical Chemistry and Applications (101 papers), Medical Imaging Techniques and Applications (36 papers) and Medical Imaging and Pathology Studies (36 papers). Adriano Duatti is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (101 papers), Medical Imaging Techniques and Applications (36 papers) and Medical Imaging and Pathology Studies (36 papers). Adriano Duatti collaborates with scholars based in Italy, France and United States. Adriano Duatti's co-authors include Alessandra Boschi, Licia Uccelli, Roberto Pasqualini, Cristina Bolzati, Andrea Marchi, Fiorenzo Refosco, L. Magon, Francesco Tisato, Roberto Rossi and Micòl Pasquali and has published in prestigious journals such as Journal of the American Chemical Society, Inorganic Chemistry and Molecules.

In The Last Decade

Adriano Duatti

129 papers receiving 2.4k citations

Peers

Adriano Duatti
Adriano Duatti
Citations per year, relative to Adriano Duatti Adriano Duatti (= 1×) peers Hans‐Jürgen Pietzsch

Countries citing papers authored by Adriano Duatti

Since Specialization
Citations

This map shows the geographic impact of Adriano Duatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriano Duatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriano Duatti more than expected).

Fields of papers citing papers by Adriano Duatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriano Duatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriano Duatti. The network helps show where Adriano Duatti may publish in the future.

Co-authorship network of co-authors of Adriano Duatti

This figure shows the co-authorship network connecting the top 25 collaborators of Adriano Duatti. A scholar is included among the top collaborators of Adriano Duatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriano Duatti. Adriano Duatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duatti, Adriano, et al.. (2023). Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry. Molecules. 28(3). 1487–1487. 16 indexed citations
2.
Duatti, Adriano. (2023). The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?. EJNMMI Radiopharmacy and Chemistry. 8(1). 17–17. 1 indexed citations
3.
Martini, Petra, Alessandra Boschi, Lorenza Marvelli, et al.. (2021). Synthesis and Characterization of Manganese Dithiocarbamate Complexes: New Evidence of Dioxygen Activation. Molecules. 26(19). 5954–5954. 14 indexed citations
4.
Bolzati, Cristina & Adriano Duatti. (2020). The emerging value of 64Cu for molecular imaging and therapy. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 64(4). 329–337. 11 indexed citations
5.
Duatti, Adriano. (2020). Review on 99mTc radiopharmaceuticals with emphasis on new advancements. Nuclear Medicine and Biology. 92. 202–216. 108 indexed citations
6.
Jalilian, Amir Reza, João Alberto Osso, Matthew Harris, et al.. (2020). IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 64(4). 338–345. 7 indexed citations
7.
Boschi, Alessandra, Micòl Pasquali, Claudio Trapella, et al.. (2018). Design and Synthesis of 99mTcN-Labeled Dextran-Mannose Derivatives for Sentinel Lymph Node Detection. Pharmaceuticals. 11(3). 70–70. 5 indexed citations
8.
Boschi, Alessandra, Petra Martini, Emilija Janevik-Ivanovska, & Adriano Duatti. (2018). The emerging role of copper-64 radiopharmaceuticals as cancer theranostics. Drug Discovery Today. 23(8). 1489–1501. 73 indexed citations
9.
Martini, Petra, Alessandra Boschi, Gianfranco Cicoria, et al.. (2018). In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals. Applied Radiation and Isotopes. 139. 325–331. 32 indexed citations
10.
Villano, Carlo, Angelina Cistaro, Andrea Bruno, et al.. (2016). Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results. Cancer Biotherapy and Radiopharmaceuticals. 31(5). 159–167. 51 indexed citations
11.
Martini, Petra, Alessandra Boschi, Gianfranco Cicoria, et al.. (2016). A solvent-extraction module for cyclotron production of high-purity technetium-99m. Applied Radiation and Isotopes. 118. 302–307. 24 indexed citations
12.
Pawlak, Dariusz, et al.. (2015). Chemistry and bifunctional chelating agents for binding <sup>177</sup>Lu. Current Radiopharmaceuticals. 8(2). 86–94. 18 indexed citations
13.
Duatti, Adriano. (2014). Molecular imaging with endogenous and exogenous ligands: The instance of antibodies, peptides, iodide and cupric ions. Nuclear Medicine and Biology. 42(3). 215–218. 4 indexed citations
14.
Boschi, Alessandra, Alessandro Massi, Licia Uccelli, Micòl Pasquali, & Adriano Duatti. (2010). PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals. Nuclear Medicine and Biology. 37(8). 927–934. 14 indexed citations
15.
Teodoro, Rodrigo, et al.. (2008). Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nuclear Medicine and Biology. 35(4). 401–411. 70 indexed citations
16.
Boschi, Alessandra, Licia Uccelli, Adriano Duatti, et al.. (2004). A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. Nuclear Medicine Communications. 25(7). 691–699. 45 indexed citations
17.
Baraldi, Pier Giovanni, Romeo Romagnoli, Adriano Duatti, et al.. (2000). Synthesis of hybrid distamycin–cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents. Bioorganic & Medicinal Chemistry Letters. 10(12). 1397–1400. 7 indexed citations
18.
Uccelli, Licia, Cristina Bolzati, Alessandra Boschi, et al.. (1999). Design and synthesis of a redox-active tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)−]. Nuclear Medicine and Biology. 26(1). 63–67. 4 indexed citations
19.
Bolzati, Cristina, Licia Uccelli, Fiorenzo Refosco, et al.. (1998). Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o- hydroxyphenyl) diphenylphosphine. Nuclear Medicine and Biology. 25(1). 71–76. 6 indexed citations
20.
Johnson, Gerald, et al.. (1996). Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium. Journal of Nuclear Cardiology. 3(1). 42–54. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026